Clinical Trial

Fractional CO2 Laser-assisted Delivery of Hyaluronic Acid, Ascorbic Acid and Sodium DNA For Enhancing Facial Skin Quality in Individuals Over the Age of 30

Study acronym: FCLADHAAASDFSQ
Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated January 29, 2026 (before its estimated February 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
Evaluate the effectiveness of topical hyaluronic acid, ascorbic acid, and sodium DNA following ablative fractional laser treatment in objectively reversing facial skin alterations induced by photoaging.
Trial Details
NCT Number NCT07376148
Lead Sponsor Instituto de Oftalmología Fundación Conde de Valenciana
Conditions Skin Quality Improvement, Photo-aged Skin, Drug Delivery Systems
Enrollment 30 participants
Start Date 2025-11-07
Primary Completion 2026-02-28 (estimated)
Study Completion 2026-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-29